Conversations in Drug Development Trends

SEPTEMBER 20, 2023

Download our poster today. The post Bioanalysis through automation: Our top four takeaways appeared first on Worldwide Clinical Trials. Time Savings: With the increased quality and throughput, we can validate assays in just a few days as opposed to weeks.   Want to learn exactly how we did it?

Clinical Trials 87

Clinical Trials Laboratories Trials 87

Fierce BioTech

JULY 28, 2023

State of Clinical Inventory and Sample Management for Clinical Trials This report summarizes the survey findings from biopharma professionals on the impacts of inefficient, manual processes for managing clinical supply and samples on budgets, timelines, data integrity, and patients — and the need for change. Download here!

Clinical Trials 52

Clinical Trials Clinical Supply Trials Research 52

PPD

MARCH 21, 2024

When participating in clinical trials, pediatric populations require distinct considerations for their safety and well-being — which can present unique challenges for drug developers. Five Strategies to Tailor Your Pediatric Clinical Trials to the Child’s Needs 1.

Clinical Trials 52

Clinical Trials Trials Drug Development Treatment 52

The Pharma Data

AUGUST 7, 2020

The governing body claims this proposal could have positive effects on mitigating burdensome requirements for gene therapy clinical trials in the future. In this light, Pharma IQ’s weekly round-up focuses on advancing therapies and clinical trials to combat Covid-19. Dr. Francis S.

Clinical Trials 52

Clinical Trials Trials Packaging Therapies 52

Advarra

JUNE 14, 2024

A regulatory binder is essential for managing clinical trial documents, ensuring regulatory compliance, and facilitating audits. It organizes critical documents; provides easy access for trial monitors, auditors, and regulatory authorities; and serves as a reference for the research team.

Clinical Trials 40

Clinical Trials Trials Compliance FDA 40

PPD

NOVEMBER 30, 2023

These shifts are a prelude to further change and progress in the clinical trial landscape in 2024. Overall, new technological approaches applied in these settings show remarkable potential to make trials more robust, promote more reliable data acquisition and keep trials on-time and on-budget. This year, the U.S.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

Crucial Data Solutions

MAY 31, 2023

Clinical trials continue to move closer to patients. Many patients, now, can participate fully in clinical trials largely from home by utilizing remote data collection technologies such as ePRO, eConsent, virtual visits, and more. They do so, largely, from mobile devices – often their very own smartphones.

Clinical Trials 52

Clinical Trials Trials Compliance Research 52

The Pharma Data

JANUARY 20, 2021

21, 2021 /PRNewswire/ — Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX: CALTX) (NASDAQ: CALT) today announced that all 360 patients have been enrolled for the global Phase 3 clinical trial NefIgArd, which investigates the effect of Nefecon® versus placebo in patients with primary IgA nephropathy (IgAN).

Trials 52

Trials Clinical Trials Pharmaceutical Companies Treatment 52

Fierce BioTech

MAY 30, 2024

Quantify Cancer With Methylation-Based ctDNA Detection Download this resource to accelerate your oncology clinical trials, optimize patient enrollment, and monitor minimal residual disease and molecular response effectively.

Clinical Trials 52

Clinical Trials DNA Trials Therapies 52

The Pharma Data

OCTOBER 19, 2020

We remain committed to further progressing our trial preparations, as we look forward to initiating a U.S. Phase 2 trial for Berubicin during the first quarter of 2021.” In addition to its manufacturing efforts, the Company has also made progress in its clinical trial preparations. .

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Treatment 52

Fierce BioTech

MAY 31, 2024

Generative AI: Powering the next era of life sciences innovations Download this eBook to explore how generative AI is revolutionizing life sciences. Learn to accelerate drug discovery through AI-powered protein folding, enhance clinical trials with data analysis, and optimize manufacturing with real-time AI monitoring.

Science 52

Science Clinical Trials Trials Drugs 52

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52

The Pharma Data

JANUARY 12, 2021

a biopharmaceutical company focused on the development of first-in-class therapeutics for the treatment of cancer, today announced the completion of the Phase 1b clinical trial conducted by the NCI with its lead clinical candidate zotiraciclib (ZTR/TG02), a potent oral cyclin-dependent kinase 9 (CDK9) inhibitor. .

Clinical Trials 52

Clinical Trials Trials Treatment Pharmaceuticals 52

The Pharma Data

DECEMBER 8, 2020

Download Your Copy. We respect your privacy, by clicking “Download Your Copy” you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. . Download Your Copy. . Download Your Copy.

Science 52

Science Clinical Trials Compliance Trials 52

The ChEMBL-og

APRIL 16, 2024

See [link] and INN clinical candidate drugs (assigned as max_phase = 2 based on INN guidance that states “As a general guide, the development of a drug should progress up to the point of clinical trials (phase II) before an application is submitted to the INN Secretariat for name selection.”

Clinical Trials 108

Clinical Trials FDA Cell Based Assays Compound Screening 108

Perficient: Drug Development

AUGUST 2, 2023

For learning purposes, you can request a trial license as well. Purchase/Trial Sitecore TDS and SVS license Step 01: Goto the TDS site Step 02: Click on the Free Trial link Step 03: Click the Try TDS button Step 04: Submit the TDS free trial form. Step 05: After submission, you need to download a package and install it.

Packaging 52

Packaging Licensing Licensing Trials 52

Fierce BioTech

JANUARY 26, 2024

Blueprint for Modern Patient Recruitment Every day, a clinical trial is delayed due to recruitment planning issues. Discover how leading sponsors are redefining the approach to patient recruitment in clinical trials. Download now. Download now.

Clinical Trials 52

Clinical Trials Trials Science 52

The Pharma Data

DECEMBER 14, 2020

The Phase II SBIR grant is a follow-on 2–year award that will support testing of Alume’s fluorescent nerve targeting agent in an ongoing Phase 1/2 clinical trial in patients undergoing Head and Neck Surgery. View original content to download multimedia: [link]. About Alume Biosciences, Inc. SOURCE Alume Biosciences.

Clinical Trials 52

Clinical Trials Trials Clinical Development Pharmaceuticals 52

Conversations in Drug Development Trends

JUNE 13, 2024

Pharmacogenomics (PGx), the study of how genes affect a person’s response to drugs, has brought significant changes to the clinical trial industry. Download our full poster to explore the comprehensive analysis and our findings and to discover how DNA sample collection can impact the effectiveness of personalized medicine.

DNA 72

DNA Compliance Clinical Trials Trials 72

Predictive Oncology

AUGUST 8, 2024

A recent white paper released by Predictive Oncology’s highlights the challenge of late-stage clinical trial failures and the company’s ability to better navigate those obstacles and increase the probability of technical success which is a key metric in target selection, clinical trial design and pipeline replenishment.

Drug Development 52

Drug Development Clinical Trials Animal Testing Trials 52

DrugBank

OCTOBER 30, 2024

From advancing drug discovery, managing clinical trials, or developing new healthcare solutions, reliable and flexible access to quality data is essential for success. Instead of traditional CSV downloads, users receive direct access to a fully queryable, ready-to-use database within the Snowflake ecosystem.

Production 75

Production Clinical Trials Packaging Compliance 75

PPD

OCTOBER 31, 2024

From adapting to complex new trial designs to embracing cutting-edge technologies, staying ahead requires a deep understanding of the current landscape. Drug development The rising cost of clinical trials is the top challenge this year, due to increasingly complex protocol designs and difficult patient recruitment.

Drug Development 52

Drug Development Clinical Trials Trials Drugs 52

The Pharma Data

DECEMBER 20, 2020

Followed by Russia , Indonesia, and Korea, the second phase of the COVID-19 clinical trial was approved in Italy on Friday, December 18, 2020. Currently, it is smoothly progressing with the approval for Phase 2 clinical trials in four countries, and it is expected to see the results sequentially starting as early as the third quarter of 2021.

Clinical Trials 40

Clinical Trials Treatment Trials Hospitals 40

The Pharma Data

JANUARY 31, 2021

Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability profiles and strong neutralizing immune responses in a phase 1 trial. Clover plans to initiate a global phase 2/3 trial in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021.

Clinical Trials 52

Clinical Trials Vaccine Trials Virus 52

The Pharma Data

JANUARY 17, 2021

The clinical trial to evaluate the safety and efficacy of the plasma-derived medicine will have doctors Oriol Mitjà and Bonaventura Clotet as the principal researchers and is expected to begin in early 2021. View original content to download multimedia: [link]. BARCELONA, Spain , Jan. BARCELONA, Spain , Jan.

Clinical Trials 52

Clinical Trials Treatment Trials Virus 52

The Pharma Data

JANUARY 17, 2021

The results provide an opportunity for the company to pursue a pivotal Phase 2/3 clinical trial in patients with primary biliary cholangitis (PBC), based on interactions with the FDA. The trial consisted of a single ascending dose (SAD) part and a multiple ascending dose (MAD) part with dosing up to 1600mg/day.

Trials 40

Trials Clinical Trials Pharmacokinetics Small Molecule 40

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax’s CpG 1018 plus alum in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. View original content to download multimedia: [link].

Vaccine 52

Vaccine Trials Virus RNA 52

Fierce BioTech

AUGUST 1, 2023

Support for the next generation of clinical and IVD trials requires a unique, multi-specialty approach. Download here! Support for the next generation of clinical and IVD trials requires a unique, multi-specialty approach. However, these modalities add significant complexity to pharma and biotech research projects.

Clinical Trials 52

Clinical Trials Trials Research 52

Agency IQ

AUGUST 23, 2024

EMA issues more updates to prepare for clinical trials transition Offices throughout the EU—including those of the EMA—have slowed operations for the summer holiday, but that didn’t keep the EMA from publishing a stack of updated documents. Per the CTR, all clinical trials are to be moved over to the CTIS by January 30, 2025.

Clinical Trials 40

Clinical Trials Trials Regulations Production 40

The Pharma Data

JANUARY 13, 2021

Prior to joining Usona, Mr. Barrow served as Chief Operating Officer of Olatec Therapeutics where he oversaw the execution of numerous early- and late-stage clinical trials in the fields of analgesics, rheumatology, immunology and cardiovascular disease. View original content to download multimedia: [link].

Clinical Trials 52

Clinical Trials FDA Trials Production 52

Predictive Oncology

JUNE 27, 2023

Download Report Schedule a meeting With the high rate of clinical trial failures, how can we incorporate tumor heterogeneity earlier in the process? Can it really be achieved prior to clinical trials…even in the early drug discovery phase?

Clinical Trials 52

Clinical Trials Drugs Trials 52

The Pharma Data

JANUARY 13, 2021

Fast Track designation is well-timed, as we anticipate starting our Phase 2 clinical trial in hospitalized COVID-19 patients this month, and should help bring Brilacidin to patients faster in these dire times.”. A preprint supporting Brilacidin’s COVID-19 treatment potential can be downloaded at the link below.

Clinical Trials 52

Clinical Trials Trials Treatment FDA 52

The Pharma Data

DECEMBER 22, 2020

Approximately 74 patients are planned for this trial in Head and Neck Squamous Cell Carcinoma (HNSCC) and Cutaneous Squamous Cell Carcinoma (CuSCC). The trial will enroll three cohorts of patients within distinct populations – all with locally advanced, recurrent and/or metastatic HNSCC or locally advanced or metastatic CuSCC.

Clinical Trials 52

Clinical Trials Therapies Trials Production 52

Alta Sciences

JANUARY 24, 2024

Discover the Power of Driving Simulations for CNS Side-Effect Analysis blussier Wed, 01/24/2024 - 18:25 HTML Start Your Driving Trial Quickly—Simulators On-Site Driving simulator studies are a safe, efficient, and effective alternative to on-the-road driving trials for CNS-active drugs. jpg Tags Clinical Trials Weight 1

Clinical Trials 40

Clinical Trials Trials FDA Drug Development 40

PPD

MARCH 26, 2024

These trends are driving a preference for the FSP model as more and more pharmaceutical companies look for ways to ensure successful trials in a highly competitive industry. DOWNLOAD THE 2024 FSP TRENDS REPORT The post FSP Engagements Continue to Gain Popularity, Drive Success appeared first on PPD Inc.

Clinical Research 98

Clinical Research Clinical Development Pharmaceutical Companies Drug Development 98

Conversations in Drug Development Trends

MARCH 7, 2024

When conducting first-in-human (FIH) clinical trials, small to midsize pharmaceutical and biotechnology companies are faced with several crucial choices that can shape the trajectory of their drug development pathway. For additional insights, download our full white paper, “ First-in-Human Studies: IND or CTA? ”.

Clinical Trials 52

Clinical Trials Trials FDA Drug Development 52

Predictive Oncology

JUNE 28, 2023

Schedule a meeting Download case studies Optimize your formulation development challenges for biologics without disrupting your workflow.

Clinical Trials 52

Clinical Trials Virus Drug Development Trials 52